• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

活检还是不活检?我们应该对稳定的肾移植进行组织学筛查吗?

To biopsy or not to biopsy? Should we screen the histology of stable renal grafts?

作者信息

Thaunat Olivier, Legendre Christophe, Morelon Emmanuel, Kreis Henry, Mamzer-Bruneel Marie-France

机构信息

Centre de Recherche des Cordeliers, Université Pierre et Marie Curie, Paris, France.

出版信息

Transplantation. 2007 Sep 27;84(6):671-6. doi: 10.1097/01.tp.0000282870.71282.ed.

DOI:10.1097/01.tp.0000282870.71282.ed
PMID:17893596
Abstract

Chronic allograft dysfunction is currently the main cause of late allograft failure. Recent encouraging evidence suggests that it may be possible to delay the development of graft damages if adequate management is initiated early in the course of the disease. These observations have renewed interest in the performance of protocol biopsies as routine follow-up procedure for the screening of renal transplants. In the present review, we summarize the available data from the literature to determine the pros and cons of protocol renal allograft biopsies. On the basis of this evidence, we discuss the ethical concerns raised by this procedure.

摘要

慢性移植肾失功是目前移植肾晚期失功的主要原因。最近有令人鼓舞的证据表明,如果在疾病进程早期就开始进行充分的管理,有可能延缓移植肾损害的发展。这些观察结果重新引发了人们对将方案活检作为肾移植常规随访程序以筛查移植肾的兴趣。在本综述中,我们总结了文献中的现有数据,以确定方案肾移植活检的利弊。基于这些证据,我们讨论了该程序引发的伦理问题。

相似文献

1
To biopsy or not to biopsy? Should we screen the histology of stable renal grafts?活检还是不活检?我们应该对稳定的肾移植进行组织学筛查吗?
Transplantation. 2007 Sep 27;84(6):671-6. doi: 10.1097/01.tp.0000282870.71282.ed.
2
Protocol biopsies after kidney transplantation.肾移植后的方案活检。
Transpl Int. 2005 Feb;18(2):131-9. doi: 10.1111/j.1432-2277.2004.00020.x.
3
Protocol transplant biopsies: are they really needed?移植活检方案:它们真的有必要吗?
Clin J Am Soc Nephrol. 2006 Jan;1(1):130-7. doi: 10.2215/CJN.00350705. Epub 2005 Nov 9.
4
Our approach to a renal transplant biopsy.我们的肾移植活检方法。
J Clin Pathol. 2010 Jan;63(1):26-37. doi: 10.1136/jcp.2009.067983. Epub 2009 Oct 22.
5
Chronic allograft nephropathy: what have we learned from protocol biopsies?慢性移植肾肾病:我们从计划性活检中学到了什么?
Transplantation. 2008 Apr 15;85(7 Suppl):S38-41. doi: 10.1097/TP.0b013e318169c5d0.
6
Insights into subclinical rejection.亚临床排斥反应的见解。
Transplant Proc. 2004 Mar;36(2 Suppl):71S-73S. doi: 10.1016/j.transproceed.2003.12.051.
7
Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.在扩大标准供体肾移植中采用基于西罗莫司的三联免疫抑制联合抗胸腺细胞球蛋白诱导治疗。
Nephrology (Carlton). 2008 Feb;13(1):80-6. doi: 10.1111/j.1440-1797.2007.00866.x.
8
[Screening biopsies in kidney transplantation: from subclinical acute rejection to chronic allograft lesions].[肾移植中的筛查活检:从亚临床急性排斥反应到慢性移植肾病变]
Nephrol Ther. 2008 Oct;4 Suppl 3:S192-9. doi: 10.1016/S1769-7255(08)74234-2.
9
[The usefulness of protocol biopsies after kidney transplant: pros and cons].[肾移植后方案活检的效用:利弊]
G Ital Nefrol. 2010 Jul-Aug;27(4):339-52.
10
Biopsy diagnostics in renal allograft rejection: from histomorphology to biological function.肾移植排斥反应中的活检诊断:从组织形态学到生物学功能
Transpl Int. 2009 Oct;22(10):945-53. doi: 10.1111/j.1432-2277.2009.00885.x. Epub 2009 Apr 28.

引用本文的文献

1
Magnetic resonance elastography vs. point shear wave ultrasound elastography for the assessment of renal allograft dysfunction.磁共振弹性成像与点剪切波超声弹性成像在评估肾移植功能障碍中的比较。
Eur J Radiol. 2020 May;126:108949. doi: 10.1016/j.ejrad.2020.108949. Epub 2020 Mar 10.
2
Benefits and risks of protocol biopsies in pediatric renal transplantation.小儿肾移植中协议活检的利弊。
Pediatr Nephrol. 2019 Apr;34(4):593-598. doi: 10.1007/s00467-018-3959-6. Epub 2018 May 3.
3
Posttransplant peripheral blood donor-specific interferon-γ enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients.
移植后外周血供者特异性干扰素-γ酶联免疫斑点试验可区分肾移植受者亚临床排斥反应和新发供者特异性同种抗体的风险。
Kidney Int. 2017 Jul;92(1):201-213. doi: 10.1016/j.kint.2016.12.024. Epub 2017 Mar 6.
4
Lymphoid Neogenesis and Tertiary Lymphoid Organs in Transplanted Organs.移植器官中的淋巴新生与三级淋巴器官
Front Immunol. 2016 Dec 27;7:646. doi: 10.3389/fimmu.2016.00646. eCollection 2016.
5
Urine Fibrosis Markers and Risk of Allograft Failure in Kidney Transplant Recipients: A Case-Cohort Ancillary Study of the FAVORIT Trial.肾移植受者尿液纤维化标志物与移植肾失功风险:FAVORIT试验的病例队列辅助研究
Am J Kidney Dis. 2017 Mar;69(3):410-419. doi: 10.1053/j.ajkd.2016.10.019. Epub 2016 Dec 23.
6
Recent advances in renal transplantation: antibody-mediated rejection takes center stage.肾移植的最新进展:抗体介导的排斥反应成为焦点。
F1000Prime Rep. 2015 May 12;7:51. doi: 10.12703/P7-51. eCollection 2015.
7
A new clinical prediction tool for 5-year kidney transplant outcome.一种用于预测肾移植5年预后的新型临床预测工具。
Am J Kidney Dis. 2014 Apr;63(4):549-51. doi: 10.1053/j.ajkd.2014.01.004.
8
Biomarkers for kidney transplant rejection.用于肾移植排斥反应的生物标志物。
Nat Rev Nephrol. 2014 Apr;10(4):215-25. doi: 10.1038/nrneph.2013.281. Epub 2014 Jan 21.
9
Evaluation of protocol biopsy utility 12 months after renal transplantation: a multicenter observational analysis.肾移植术后12个月方案活检效用的评估:一项多中心观察性分析。
J Transplant. 2012;2012:781263. doi: 10.1155/2012/781263. Epub 2012 Sep 5.
10
Detecting adaptive immunity: applications in transplantation monitoring.检测适应性免疫:在移植监测中的应用。
Mol Diagn Ther. 2010 Feb 1;14(1):1-11. doi: 10.1007/BF03256348.